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Microbiota modulation by 1 
diet in humans: prebiotics, 2 
fibres and other compounds. 3 
ABSTRACT 4 
Based on the relevance of the intestinal microbiota on health, this article is focused in the effect 5 
of diet, and its components, in modulating the activity of the colonic flora. For this purpose, we 6 
described briefly previous evidences regarding the effects of different prebiotics on the microbial 7 
balance, from the classics as fructo-oligosaccharides (FOS), galact-oligosaccharides (GOS) or 8 
inulin to the most innovative as resistant starch. In addition, it will be highlighted the importance of 9 
other compounds associated with fibre intake, as polyphenols, whose prebiotic/antimicrobial 10 
effects remains to be elucidated. Finally, some perspectives for future research in this subject 11 
were pointed up, which we believe may represent a considerable advance in knowledge of this 12 
topic. 13 
 14 
INTRODUCTION 15 
With the increased commercialization of functional foods, which has occurred in the last 16 
decades, foods with probiotics, prebiotics or both have been used by most of the population. 17 
The human gastrointestinal tract (GIT) harbours a very complex and dynamic microbial 18 
community which, in number, exceeds by an order of magnitude the number of host cells (1). 19 
Different microorganisms and levels are found throughout the gastrointestinal tract, as 20 
corresponds with the different ecological niches present from mouth to colon; the stomach and 21 
upper bowel being sparsely populated whilst the colon is heavily colonized. The process of 22 
establishment of this microbiota starts at birth and later develops depending on interplay 23 
between genetics, environment and diet. This microbiota plays an important role in human 24 
health not only due to its participation in the digestion process, but also for its critical functions on 25 
the development of the gut and the immune system. Indeed, it has been demonstrated that this 26 
bacterial colonization of the intestine is needed for the development of oral tolerance (2) and for 27 
the establishment of the mucosal barrier and the maintenance of intestinal homeostasis (3). The 28 
microbiota is also needed for a proper morphological development of the intestine (4) and it 29 
regulates host metabolism (5). In addition, it plays an essential role for an adequate immune 30 
development (6). 31 
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On the other hand, the human gastrointestinal tract is one of the larger surfaces of exposure to 32 
the outer environment being an important area of exchange of information with the outer 33 
environment. There are more lymphoid cells associated with the gastrointestinal mucosa than 34 
with the spleen, peripheral lymph nodes and blood taken together, more than an 80% of the B-35 
cells in the body are gut-associated, making the gut the biggest immune organ (7). Taking into 36 
account these considerations, it is obvious that the intestinal microbiota provides the most 37 
important contact with the environment for the host and a barrier against harmful food 38 
components and pathogenic bacteria.  39 
The new molecular techniques have enormously increased our knowledge and helped to 40 
determine the community structure of the gut microbiota. They have allowed identifying three 41 
human microbiota enterotypes and assessing the effect of diet (8). Determining the microbiome 42 
of healthy as compared with disease individuals has allowed identifying aberrancies related to 43 
several human diseases and alterations related with different life stages, such as senescence or 44 
prematurity. However, most of our microbiota data today are derived from results obtained from 45 
faecal samples and, therefore, represent the microbiota present in the colonic lumen. Studies on 46 
other intestinal locations, such as the mucosa, are much limited although differences appear to 47 
exist (9) and alterations related with disease have also been observed (10). 48 
 49 
EVIDENCES OF STUDIES WITH PREBIOTICS IN HUMANS 50 
A dietary prebiotic is a selectively fermented ingredient that results in specific changes, in the 51 
composition and/or activity of the gastrointestinal microbiota, thus conferring benefits upon host 52 
health (11). Candidate prebiotics must fulfil the following criteria (12): (a) resistance to gastric acidity 53 
and hydrolysis by mammalian enzymes and gastrointestinal absorption; (b) substrate of 54 
fermentation by intestinal microorganisms belonging to the human microbiota; (c) selective 55 
stimulation of the growth and/or activity of intestinal bacteria associated with health and 56 
wellbeing. The most studied prebiotic compounds are non-digestible oligosaccharides such as 57 
inulin, fructo-oligosaccharides (FOS) and galact-oligosaccharides (GOS), among others. 58 
A large part of research activity had been focused on the selection of compounds able to 59 
modify the microbiota intestinal in the colon. However, nowadays there is increased evidence 60 
that prebiotics may induce beneficial physiological effects along to the gastrointestinal tract 61 
(GIT) as well as at systemic level (13). These include, amongst others; -Selective growth of 62 
beneficial intestinal microbiota and improvement the intestinal functions. Gut microbiota is a key 63 
player in health and wellbeing with a composition in which beneficial microorganisms dominate 64 
over potentially harmful ones. Bifidobacteria and Lactobacilli constitute the traditional target of 65 
prebiotics, but other microorganisms such as Faecalibacterium prausnitzii also have ability to 66 
degrade them. Prebiotic consumption has been reported to improve intestinal functions like 67 
regularity, intestinal barrier or competitive exclusion of pathogens. -Immunomodulatory 68 
properties. Prebiotics may influence the immune system directly or indirectly through changes in 69 
the microbiota that may affect the immune response of the host. Prebiotics may also bind to 70 
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receptors of immune cells and participate in the modulation of different immune parameters. -71 
Stimulation of mineral absorption. Prebiotics help to increase Ca bioavailability by reducing 72 
intestinal pH as consequence of short chain fatty acids (SCFA) production and extending the site 73 
of mineral absorption towards the large intestine. The absorption of others minerals, such as Mg or 74 
Fe, have also been suggested to be improved too. -Reduction of risk of disease. Prebiotics 75 
reduce risk of intestinal infections by competitive exclusion, reducing intestinal pH, etc. 76 
Compounds with prebiotic properties have also been reported to promote the endocrine 77 
function of the gut, favouring the regulation of lipid metabolism, glycemia and insulin resistance; 78 
and food intake and satiety (14).  79 
However, only some of these proposed beneficial effects of prebiotics are backed by human 80 
studies. These human studies and RCTs have been performed to evaluate some potential health 81 
benefits of prebiotics including; effects on microbiota, immune system, mineral absorption and 82 
gastrointestinal disorders (Table 1).  83 
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Roberfroid et al. 
(2010) 
Walton et al. 
(2012), Cloetens 
et al (2010) 
Inulin, FOS and GOS 
are the compounds 
more tested in human 
trials able to change 
the gut flora 
composition. 
AXOS increase the 
bifidobacterias, 
decrease the proteolitic 
fermentation and 
increase the butyric 
levels in healthy adults. 
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Vulevic et al. 
(2008) 
GOS increased 
phagocytosis, NK cell 
activity and IL-10; and 
decreased IL-1, IL-6 
and TNFα, in healthy 
elderly volunteers.  
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Roberfroid et al. 
(2010) 
Calcium absorption 
was increased by 
prebiotic consumption 
in healthy adolescents 
and postmenopausal 
women.  
G
I 
d
is
o
rd
e
rs
 
Casellas et al. 
(2007),  
Lindsay et al. 
(2006),  
Friedman et al. 
(2000),  
Clark et al. (2012) 
Benefits in treating 
active of pouchitis, 
Crohn’s disease and 
ulcerative colitis and a 
reduction on colon 
cancer risk markers by 
prebiotics 
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Osborn et al. 
(2007), Arslanoglu 
et al. (2008). 
Mixture GOS/FOS 
reduced significantly 
the frequency of atopic 
eczema in babies with 
risk of allergy, and this 
effect was maintained 
during two years. 
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Table 1 Effects of prebiotic products on human health. 85 
 86 
FIBRE INTAKE AND SHORT CHAIN FATTY ACIDS  87 
Dietary fibre includes non-starch polysaccharides, oligosaccharides, lignin and resistant starch, 88 
compounds that reach the colon without being absorbed in a healthy human gut. Increased 89 
consumption of dietary fibre is widely recommended in occidental societies, to improve health. 90 
Generous intake of fibre reduces risk for developing some chronic diseases like coronary heart 91 
disease, stroke, hypertension, diabetes or obesity (15). In addition, due to its indigestible nature, 92 
these compounds may exert some beneficial effects on the gastrointestinal tract. In this sense, 93 
insoluble fibre, like cellulose and lignin, is only fermented to a limited extent in the colon and 94 
contributes to increase faecal bulk, enhance gut motility and reduce transit time (15), while soluble 95 
fibre with high fermentability, such as pectin and resistant starch, are associated with the 96 
production of the volatile SCFA, together with lactate, CO2, methane and hydrogen (16). The 97 
main SCFA are, in this order, acetate, propionate and butyrate, in a molar ratio of approximately 98 
3:1:1, respectively, in the proximal and distal colon (17). In the last years, a great number of actions 99 
have been attributed to SCFA, whose concentration has been associated with reduced risk of 100 
some diseases, such as the irritable bowel syndrome, inflammatory bowel disease, cardiovascular 101 
disease and cancer (Figure 1). Numerous studies have pointed butyrate as a key factor in the 102 
maintenance of colon health, being the principal energy source for colonocytes, enhancing 103 
normal colonic cell proliferation or exerting antioxidant and anti-inflammatory properties, this has 104 
led to consider it as important preventive factor of colon cancer (18). O’Keefe et al., compared 105 
the excretion of SCFA in three healthy populations with different nutritional characteristics and 106 
different risk level of colon cancer: Native Africans (low risk), African Americans (high risk) and 107 
Caucasian Americans (high risk). They found that acetate, propionate and butyrate were higher 108 
in Native Africans than in the other two groups. This observation was attributed, by the authors, to 109 
their diet rich in whole-grain cereals and resistant starch (19). It is thought that butyrate excretion is 110 
mainly due to the fermentation of resistant starch, and there are some studies that confirm this 111 
hypothesis. In a population study carried out by Segal et al., was showed that total SCFA and 112 
butyrate excretion levels were greater in native Africans than those in Europeans living locally, 113 
despite of the higher intake of total dietary fibre in the latter. This could be due to an increased 114 
consumption of resistant starch in the Africans (20). Some dietary intervention works have 115 
supported these observations in epidemiological studies. Jenkins et al., in a study conducted in 24 116 
healthy subjects, found higher levels of faecal butyrate with a diet rich in resistant starch (21). 117 
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However, other authors found that a high intake of resistant starch, not only increases butyrate 118 
levels, but also total SCFA and acetate (22). Based on these results, it seems obvious that resistant 119 
starch is the main source for butyrate synthesis, however further studies are needed to deepen 120 
this association.  121 
Propionate has been related with hepatic lipogenesis regulation, decrease serum and hepatic 122 
cholesterol and triglycerides levels, and appetite control (23). Tabernero et al., analysing the in 123 
vitro fermentability of different fibre sources, found that cereal fibre was the main contributor to 124 
propionate production (24). Cereals are rich in β-glucans and arabinoxylans, soluble fibre types 125 
which have been associated with propionate synthesis by other authors (25). These scientific 126 
evidences could lay the groundwork for the blood lipid modulation by the diet. In this way, the 127 
American Heart Association recommends an increased intake of carbohydrates, especially 128 
complex carbohydrates and fibre to prevent cardiovascular disease. Finally, acetate, as well as 129 
propionate, is involved in lipid metabolism, being the primary substrate for cholesterol synthesis. 130 
Bridges et al., by a dietary intervention found that acetate serum levels were higher when 131 
subjects were fed with a diet rich in oat-bran (26), food rich in fermentable fibres. These evidences 132 
confirm that, not only is important the type of fibre but also the source of this fibre is a factor to 133 
consider.  134 
SCFA’s synthesis not only depends on diet, but also another factors like number and types of 135 
bacteria in the colon and gut transit time (27). These compounds can, in turn, modulate intestinal 136 
microbiota. In this sense, it has been seen that total SCFA in general and butyrate in particular 137 
promotes the growth of Lactobacilli and Bifidobacteria species, which have been related with an 138 
improved health. 139 
 140 
OTHER COMPOUND: PHYTO-COMPOUNDS   141 
Polyphenols are common constituents of the human diet, present in most foods and beverages 142 
of plant origin (as fruits, vegetables, tea and coffee, red wine, chocolate and olive oil). Apart 143 
from its role as antioxidants, the consumption of polyphenols has been suggested to have diverse 144 
benefits such as improved gut health. There are few studies in the literature analysing the effect 145 
of polyphenols on modulation of human microbiota and most of the research in this area comes 146 
from intervention studies performed with isolated of different selected polyphenols or polyphenol-147 
rich foods or beverages. Recent studies carried out in animals and human volunteers revealed 148 
that polyphenol-rich food such as red wine (28) tea (29) or cocoa (30; 31) produces modifications in 149 
intestinal bacteria populations. While Queipo-Ortuño et al. have recently published changes in 150 
the concentration of Proteobacteria, Fusobacteria, Firmicutes and Bacteroidetes in humans after 151 
consuming alcoholic beverages (red wine and gin) and de-alcoholizated red wine (28), animal 152 
studies have found a lower proportion of Clostridium and Lactobacilli in polyphenol-treated rats 153 
respect control ones (32).  By other hand, the effects of cocoa flavanols remain controversial: an 154 
increase in Lactobacilli and Bifidobacteria has been described in humans (31), but evidences in 155 
animal studies showed a decrease of Bacteroides, Clostridium and Staphilococcus (30). Although 156 
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the differences in the research that analyses the relationship of polyphenols with the microbiota 157 
make them difficult to compare, the evidence seems strong enough to take into account the 158 
intake of these phyto-compounds in assessing the effect of probiotics and prebiotics on intestinal 159 
flora. It appears that the stimulatory or antimicrobial effect of polyphenols depends largely on the 160 
microbial group. Both, the effect on decreasing pathogenic bacteria as increasing the beneficial 161 
ones, they could contribute in the maintenance of a balanced microbiota and, hence, in our 162 
health.  163 
 164 
DIETARY PATTERNS AND MICROBIOTA  165 
Most of the previous research about diet and microbiota addressed the effect of single food 166 
components on different groups of bacteria. There are solid evidences that prebiotics, fibre and 167 
other dietary compounds affect bacterial populations that live in our colon. However, the 168 
interrelation between diet and intestinal microbiota is very complex in the extent to which 169 
bacteria are affected by the compounds that reach the colon from the diet but also they 170 
produce changes in some of these compounds, so analyse both a bidirectional relationship. The 171 
complex interaction between the different compounds consumed as a part of a whole diet, 172 
together with the effect of other factors as antibiotic use or stress makes difficult to clarify this 173 
association. Furthermore, the effect of one or more isolated compounds on bacterial populations 174 
is not extrapolated to the context of a diet. The combined intake of foods in a diet may modify 175 
the effect of the individual components on the microbiota due to the existence of synergies and 176 
antagonisms between them. In this sense, Mediterranean diet has been proposed in recently 177 
studies as a protector risk factor of colon cancer, whilst Western diet characterized by high intake 178 
or red and processed meat and refined carbohydrates, have the opposite effect. Some authors 179 
propose that the protective effect of Mediterranean diet is due the combination of food sources 180 
with fibre and the intake of other compounds such as polyphenols associated (24). At this point, 181 
many questions remains in the air, How much time is necessary to modify the intestinal microbiota 182 
changing food intake?, Are the amounts of fibre, prebiotics and phyto-compounds that we 183 
consume in a normal diet capable to impact on our flora or it would be necessary the use of 184 
supplements?. In this regard, despite of the lack of studies in humans, works conducted in animals 185 
showed an increase in Firmicutes and a decrease in Bacteroidetes phylum by consequence of 186 
being fed with a Western diet (33).  This ratio Firmicutes/Bacteroidetes is often used in humans as  187 
an indicator of microbial balance.  188 
 189 
CONCLUSION AND PERSPECTIVES OF FUTURE 190 
It is well demonstrated that the intestinal microbiota constitutes an important factor for the health 191 
and well-being. The rationale for developing strategies aiming at the modulation of the colonic 192 
microbiota derives from this demonstration on the importance of microbiota on host’s health and 193 
these microbiota aberrancies constitute clear targets for the future development of dietary 194 
interventions directed to correct them. Now, it is time to take advantage of this omics era where 195 
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the metagenomics is allowing us to know in deep the microbial composition of different human 196 
populations and which bacterial groups constitute targets for modulating in different human 197 
populations. To this regard, dietary manipulation represents a potential tool for the rational and 198 
directed manipulation of the human intestinal microbiota in the context of the health and 199 
disease. 200 
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Figure 1 Diet, microbiota and health effects. 254 
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